© 2025 MergersCorp M&A International.
is a global brand operating through a number of professional firms and constituent entities located throughout the world to provide M&A Advisory and other client related professional services. The Member Firms are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit us on our website https://dev.cherrycoding.com/mergerscorp/disclaimer. MergersCorp M&A International is not a registered broker-dealer under the U.S. securities laws.
This website does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by MergersUS Inc. or any other third party regardless of whether such security, product or service is referenced in this website. Furthermore, nothing in this website is intended to provide tax, legal, or investment advice and nothing in this website should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction.MergersCorp M&A International franchising program is not offered to individuals or entities located in the United States
The franchising program is offered by MergersUK Limited a UK Company with registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom
这是一家快速成长的云原生 SaaS 公司,总部位于班加罗尔,在美国、英国和欧洲均设有办事处,专门为全球生命科学行业提供药物警戒 (PV) 和临床试验 IT 解决方案。 该公司提供的一体化平台集受理、病例处理、监管提交和信号检测于一体,可将 IT 成本降低 70%,合规时间缩短 30%。
公司成立于 2017 年,在印度拥有一支由 65 多名员工组成的专业化团队,为 15 个国家的 100 多家直接客户和 160 多家终端客户提供支持。
带 AS2 网关的统一 PV 数据库
网络、电子邮件和 MICC 接收模块
案例处理、自动叙述、信号检测
E2B R2/R3 支持和实时分析
集成 CTMS、EDC、eTMF、ePRO、IWRS 和 eConsent 模块
由人工智能驱动的自动病例预订、分流和处理系统
端到端统一系统(与传统堆栈中的零散工具相比)
内置监管合规工具(如提交和报告)
受到印度十大制药公司前三名的信赖
在印度、美国、英国和更广泛的欧洲市场占据重要地位
嵌入全球 CRO,并通过合作伙伴关系(如 Wipro、Persistent、Cognizant)进行扩展
在 250 多项临床研究中得到积极应用
2025:以人工智能为主导的药物警戒工作流程自动化
2030 年:成为全球前十大光伏 IT 供应商,占据 30% 的市场份额
© 2025 MergersCorp M&A International is a global brand operating through a number of professional firms and constituent entities (“Members”) located throughout the world to provide Investment Banking, Corporate Finance, and Advisory Services and other client-related professional services. The Member Firms (“Members”) are constituted and regulated in accordance with relevant local regulatory and legal requirements. For more details on the nature of our affiliation, please visit our Disclaimer: https://mergerscorp.com/disclaimer. MergersCorp M&A International's franchising program is not offered to individuals or entities located in the United States.
The franchising program is offered by MergersUK Limited, a UK Company with its registered office at 71-75 Shelton Street, Covent Garden, London, WC2H 9JQ, United Kingdom.
MergersCorp M&A International provides strategic business advisory services, including preparing companies for growth and capital access. Through partnerships with licensed investment bankers, clients can access tailored capital-raising solutions.
U.S. Investment Banking Securities transactions are exclusively conducted by Spektrum Capital Advisors LLC, a Registered Representative of, and Securities Products offered through, BA Securities, LLC, a FINRA-registered broker-dealer. Check the background of investment professionals associated with this site on Broker Check.
This website is operated by MergersUS Inc a US Corporation with registered office at





描述
这是一家快速成长的云原生 SaaS 公司,总部位于班加罗尔,在美国、英国和欧洲均设有办事处,专门为全球生命科学行业提供药物警戒 (PV) 和临床试验 IT 解决方案。 该公司提供的一体化平台集受理、病例处理、监管提交和信号检测于一体,可将 IT 成本降低 70%,合规时间缩短 30%。
公司成立于 2017 年,在印度拥有一支由 65 多名员工组成的专业化团队,为 15 个国家的 100 多家直接客户和 160 多家终端客户提供支持。
核心平台功能
带 AS2 网关的统一 PV 数据库
网络、电子邮件和 MICC 接收模块
案例处理、自动叙述、信号检测
E2B R2/R3 支持和实时分析
集成 CTMS、EDC、eTMF、ePRO、IWRS 和 eConsent 模块
差异化
由人工智能驱动的自动病例预订、分流和处理系统
端到端统一系统(与传统堆栈中的零散工具相比)
内置监管合规工具(如提交和报告)
受到印度十大制药公司前三名的信赖
战略足迹
在印度、美国、英国和更广泛的欧洲市场占据重要地位
嵌入全球 CRO,并通过合作伙伴关系(如 Wipro、Persistent、Cognizant)进行扩展
在 250 多项临床研究中得到积极应用
愿景
2025:以人工智能为主导的药物警戒工作流程自动化
2030 年:成为全球前十大光伏 IT 供应商,占据 30% 的市场份额
Basic Details
Target Price:
$ 0
Gross Revenue
$3,000,000
EBITDA
$1,000,000
Business ID:
L#20250961
Country
印度
详情
Similar Businesses
Published on 12 7 月, 2025 在 5:29 下午. 更新 12 7 月, 2025 在 5:29 下午
消费品和服务营销与销售 SaaS 平台
待定
软件和 SAAS
用于社交聆听和数据分析的 SAAS 自然语言处理业务
€1,000,000
软件和 SAAS
历史悠久的领先数字商务 Magento 和 Shopify 扩展提供商
$22,950,000
软件和 SAAS
历史 WordPress 软件插件页面创建器
$9,500,000
软件和 SAAS
SAAS 软件解决方案与人工智能/移动语言
$90,000,000
软件和 SAAS
领先的在线 SAAS 销售 Power Points PPTX 演示文稿和幻灯片
$28,000,000
软件和 SAAS
PREVIOUS PROPERTY
历史悠久的领先数字商务 Magento 和 Shopify 扩展提供商
NEXT PROPERTY
意大利高级豪华游艇制造业务